Dernières nouvelles pour Annovis Bio (NYSE:ANVS) Stock

ANNOVIS BIO

Annovis Bio

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Annovis Bio Inc

Health Care

Press Releases

Annovis to Host Patients' Live Forum on February 27, 2025

News

Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment

Earnings

Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Annovis to Attend AD/PD™ 2025 with Extensive Scientific Program

Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE

Management

Annovis Bio Appoints Hui Liu as Director of Biostatistics

Annovis Provides Corporate Updates and Reports First Quarter 2025 Financial Results

Annovis to Host Webinar and Live Q&A on June 24, 2025

Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance

Annovis to Attend the AAIC 2025 with Four Poster Presentations

ANVS

ABVC BioPharma

Acrivon Therapeutics, Inc. - Common Stock

Acrivon Therapeutics

Adverum Biotechnologies, Inc. - Common Stock

Adverum Biotechnologies

Aligos Therapeutics

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

Actinium Pharma

Precision BioSciences, Inc. - Common Stock

Precision BioSciences

Gain Therapeutics

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Jasper Therapeutics, Inc. - Class A Common Stock

Jasper Therapeutics

Kalaris Therapeutics, Inc. - Common Stock

Kalaris Therapeutics

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

LakeShore Biopharma Co., Ltd - Ordinary Shares

LakeShore Biopharma

MAIA Biotechnology

MEI Pharma

Mersana Therapeutics, Inc. - Common Stock

Mersana Therapeutics

Ovid Therapeutics

PDS Biotechnology Corporation - Common Stock

PDS Biotechnology

PepGen

Prelude Therapeutics Incorporated - Common Stock

Prelude Therapeutics

RenovoRx

Serina Therapeutics

Senti Biosciences

vTv Therapeutics Inc. - Class A Common Stock

Comments

Annovis Bio

Actualités

Dernières nouvelles pour Annovis Bio (NYSE:ANVS) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL